科学图书馆
-
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al. -
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney DiseaseS Garcia, RJ Cubeddu, RT Hahn et al.
-
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic StenosisB Tamarappoo, D Han, D Berman et al.
-
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVRNM Van Mieghem, M Unverdorben, the ENVISAGE-TAVI AF Investigators.
-
Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart DiseaseTM Sundt; H Jneid et al.
-
Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJ Butler, G Filippatos, TJ Siddiqi et al.
-
Acute Aortic Syndrome Revisited: JACC State-of-the-Art ReviewI Vilacosta, JAS Román , R di Bartolomeo et al.
-
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Rheumatic Aortic StenosisA Mentias, M Saad ,MY Desai et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
